Agshin Taghiyev to Protein Kinase Inhibitors
This is a "connection" page, showing publications Agshin Taghiyev has written about Protein Kinase Inhibitors.
Connection Strength
0.053
-
Rokhlin OW, Guseva NV, Taghiyev AF, Glover RA, Cohen MB. KN-93 inhibits androgen receptor activity and induces cell death irrespective of p53 and Akt status in prostate cancer. Cancer Biol Ther. 2010 Feb; 9(3):224-35.
Score: 0.021
-
Rokhlin OW, Taghiyev AF, Bayer KU, Bumcrot D, Koteliansk VE, Glover RA, Cohen MB. Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival. Cancer Biol Ther. 2007 May; 6(5):732-42.
Score: 0.017
-
Rokhlin OW, Guseva NV, Taghiyev AF, Glover RA, Cohen MB. Multiple effects of N-alpha-tosyl-L-phenylalanyl chloromethyl ketone (TPCK) on apoptotic pathways in human prostatic carcinoma cell lines. Cancer Biol Ther. 2004 Aug; 3(8):761-8.
Score: 0.015